LBX2 and neoplasm: By applying experimental tools and new technologies, such as RIP and gain- and loss-of-function assays, researchers have revealed that LBX2-AS1 is capable of modulating tumor-related biological processes, including cell proliferation, apoptosis, and migration, via complex regulatory networks involving ceRNA activity, protein–lncRNA interactions, and positive feedback loops that regulate LBX2-AS1 expression, indicating the potential benefits of therapeutic strategies that target this lncRNA.